Summary
This prediction is currently active. The BUY prediction by skatcup shows slight gains of 4.50%. This prediction currently runs until 08.12.26. The prediction end date can be changed by skatcup at any time. skatcup has 80% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w |
|---|---|
| Bayer AG | 4.50% |
| iShares Core DAX® | 0.734% |
| iShares Nasdaq 100 | -2.686% |
| iShares Nikkei 225® | -2.261% |
| iShares S&P 500 | -1.346% |
According to skatcup what are the pros and cons of Bayer AG for the foreseeable future?
Pros
Differentiated customer and product portfolio
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
High dividend yield expected
Standard Investments for future growth
Innovative
Strong uniques
Small cyclical dependencies
Well known brand
Higher EBIT margin than peer group
positive Cash Flow expected
Good rating
ROE higher than 10% per year
Growths faster than the competition
Sustainability is important
Market Leader or Top 3
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Cons
Risky balance sheet
Higher risks for its business
high free float